EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity

Carmine Siniscalchi iD, Manuela Basaglia, Antonella Tufano iD, Egidio Imbalzano iD, Pierpaolo Di Micco iD

Vaccines · 28.02.2026 · 14 (3) · 225

DOI: 10.3390/vaccines14030225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 28.02.2026. Verfasst von Carmine Siniscalchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Parma University Hospital, 43100 Parma, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but severe immune-mediated adverse event associated with adenoviral vector-based SARS-CoV-2 vaccines. Beyond its clinical relevance, VITT provides a unique human model of vaccine-triggered autoimmunity and immune-thrombosis. This review critically reassesses the immunopathogenic framework of VITT in light of recent evidence.

Methods

We conducted a structured narrative review of studies published between 2021 and 2025, focusing on clinical, epidemiological, and mechanistic data relevant to PF4 immunogenicity, platelet activation, and long-term outcomes.

Results

Current evidence supports a multistep model in which adenoviral vector components form immunogenic PF4–polyanion complexes that induce high-affinity anti-PF4 IgG antibodies. These antibodies activate platelets via FcγRIIa, amplify complement signaling, promote neutrophil extracellular trap formation, and drive endothelial perturbation, establishing a self-sustaining thrombo-inflammatory loop. Recent longitudinal studies refine earlier interpretations by distinguishing persistent anti-PF4 seropositivity from sustained platelet-activating capacity. Epidemiological data support platform-enriched risk rather than absolute platform exclusivity, with a proposed mechanistic “border zone” for incomplete phenotypes.

Conclusions

VITT represents a tractable human model of vaccine-induced autoimmunity in which innate immune activation and multivalent antigen presentation converge to break tolerance. Updated evidence clarifies antibody persistence, platform enrichment, and translational implications, while highlighting unresolved questions regarding host susceptibility and long-term immune regulation.

Schlagwörter

Stichwörter der Autor:innen

immunethrombocytopeniathrombosisvaccine

Autor:innen und Institutionen

  • Department of Internal Medicine, Parma University Hospital, 43100 Parma, Italy.
  • Department of Internal Medicine, "Federico II University" Napoli University Hospital, 80078 Naples, Italy.
  • Department of Internal Medicine, Messina University Hospital, 98121 Messina, Italy.
  • UOC Medicina Interna, P.O. Pozzuoli, ASL Napoli2 nord, 80078 Pozzuoli, Italy.

ORCID-Profile: Carmine Siniscalchi, Antonella Tufano, Egidio Imbalzano, Pierpaolo Di Micco

Zitieren

APA

Siniscalchi, C., Basaglia, M., Tufano, A., Imbalzano, E., & Di Micco, P. (2026). Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity. Vaccines, 14(3), 225. https://doi.org/10.3390/vaccines14030225

Vancouver

Siniscalchi C, Basaglia M, Tufano A, Imbalzano E, Di Micco P. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity. Vaccines. 2026;14(3):225. doi:10.3390/vaccines14030225

BibTeX
@article{Siniscalchi2026,
  author = {Siniscalchi, Carmine and Basaglia, Manuela and Tufano, Antonella and Imbalzano, Egidio and Di Micco, Pierpaolo},
  title = {Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {225},
  doi = {10.3390/vaccines14030225}
}
Kostenlos starten →